- Case report
- Open Access
Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
https://doi.org/10.1186/1532-429X-10-58
© Strijack et al; licensee BioMed Central Ltd. 2008
- Received: 25 November 2008
- Accepted: 16 December 2008
- Published: 16 December 2008
Abstract
A 35 year-old asymptomatic Caucasian female with a family history of hypertrophic cardiomyopathy (HCM) was referred for cardiologic evaluation. The electrocardiogram and transthoracic echocardiogram were normal. Cardiovascular magnetic resonance (CMR) was performed for further assessment of myocardial function and presence of myocardial scar. CMR showed normal left ventricular systolic size, measurements and function. However, there was extensive, diffuse late gadolinium enhancement (LGE) throughout the left ventricle. This finding was consistent with extensive myocardial scarring and was highly suggestive of advanced, non-ischemic cardiomyopathy. Genotyping showed a heterozygous mis-sense mutation (275G>A) in the cardiac troponin T (TNNT2) gene, which is causally associated with HCM. There have been no previous reports of such extensive, atypical pattern of myocardial scarring despite an otherwise structurally and functionally normal left ventricle in an asymptomatic individual with HCM. This finding has important implications for phenotype screening in HCM.
Keywords
- Cardiovascular Magnetic Resonance
- Sudden Cardiac Death
- Late Gadolinium Enhancement
- Hypertrophic Cardiomyopathy
- Cardiac Troponin
Case presentation
Inversion-recovery images in the vertical long-axis (2-chamber shown) view demonstrating diffuse, poorly demarcated late-gadolinium enhancement (arrows) without left ventricular enlargement or hypertrophy (LA – left atrium, LV – left ventricle).
Inversion-recovery images in the vertical short-axis view demonstrating diffuse, poorly demarcated late-gadolinium enhancement (arrows) without left ventricular enlargement or hypertrophy (LA – left atrium, LV – left ventricle).
Consent
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Declarations
Authors’ Affiliations
References
- Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE: Alpha-tropomyosin and cardiac troponin T mutations cause familiar hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994, 77: 701-12. 10.1016/0092-8674(94)90054-X.View ArticlePubMedGoogle Scholar
- Javadpour MM, Tardiff JC, Pinz I, Ingwall JS: Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. J Clin Invest. 2003, 112: 768-75.PubMed CentralView ArticlePubMedGoogle Scholar
- Moon JCC, McKenna WJ, McCrohon JA, Elliot PM, Smith GC, Pennell DJ: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003, 41: 1561-7. 10.1016/S0735-1097(03)00189-X.View ArticlePubMedGoogle Scholar
- Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M, Abe Y, Yamashina A: Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging. 2004, 22: 155-61. 10.1016/j.mri.2003.08.009.View ArticlePubMedGoogle Scholar
- Adabag AS, Maron BJ, Appelbaum E, Caitlin J, Harrigan CJ, Buros JL, Gibson M, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS: Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008, 51: 1369-74. 10.1016/j.jacc.2007.11.071.View ArticlePubMedGoogle Scholar
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.